League greats tackle melanoma research
13 April, 2007The University of Queensland (UQ) has received a $48,000 donation to its cancer research institute from cancer charity group, Mardi Jackson Foundation.
Australian scientists identify cancer cells
30 March, 2007Australian scientists have identified the leukaemia cells responsible for causing relapse after treatment in common childhood cancer.
Antibiotic resistance in plague
21 March, 2007The ability to resist many of the antibiotics used against plague has been found so far in only a single case of the disease in Madagascar. But because the same ability is present in other kinds of bacteria from a broad range of livestock, antibiotic resistance could potentially spread to other Yersinia pestis and also other bacterial pathogens.
Australia awards cervical cancer vaccine developer
07 March, 2007The University of Queensland (UQ) professor behind the world’s first cervical cancer vaccine received one of Australia’s most prestigious medical awards last night.
Human magnetic field exposure testing
07 February, 2007The Hioki Model 3470 Magnetic Field HiTester is designed to measure human exposure to magnetic flux in electromagnetic fields in accordance with IEC standards (IEC62233; EN50366) and International Commission on Non-Ionising Protection Commission (ICNIRP) guidelines.
Model language helps clinical researchers
25 January, 2007Experts at Johns Hopkins University, Duke Universit and Wake Forest University have published new language designed to help clinical researchers better disclose their financial interests in research.
Agreement for non-contact heart sensor
08 January, 2007CSIRO has announced the signing of a licensing agreement with Melbourne-based bio-technology medical device company, HD Medical Group Limited, for commercial application of its non-contact sensor technology.
New technology makes clinical research more precise
15 December, 2006The Flanders Interuniversity Institute for Biotechnology (VIB) and AlgoNomics have joined forces to develop a technology that verifies whether certain proteins induce an immune response in humans.
Research offers hope for alcoholics
12 December, 2006Scientists at Melbourne’s Howard Florey Institute have discovered a system in the brain that stops an alcoholic’s craving for alcohol, as well as preventing relapse once they have recovered from alcohol addiction.
Sea snail key to future of pain relief
11 December, 2006Research at The University of Queensland could revolutionise the treatment of pain relief with the help of a sea snail.
Australian Alzheimer's study launched
17 November, 2006An Australian study to better understand the devastating and deadly Alzheimer's disease has been launched in Melbourne.
Australian invention commercialised
28 September, 2006A Royal North Shore Hospital discovery has been commercialised by US company Beckman Coulter, manufacturer of biomedical testing equipment, through its DSL subsidiary.
Aussie team makes landmark insulin discovery
15 September, 2006A team of CSIRO scientists has determined the molecular structure of the insulin receptor, the protein on the surface of cells that mediates the effects of insulin.
Tightening regulations for clinical trials
09 August, 2006A joint task force has released recommendations to enhance and clarify the existing guidelines governing the testing of new medicines in humans following the notorious TGN1412 trial in the UK
Cosmetic therapy for motoneuronal diseases
11 July, 2006Dr Frederic Meunier, a winner of UniQuest’s annual Trailblazer innovation competition, is developing a treatment for motoneuronal diseases based on modifying botox.
